Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience-Reference-Cited by-同舟云学术

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

Published:2020-06-09 Issue:1 Volume:21 Page:
ISSN:1129-2369
Container-title:The Journal of Headache and Pain
language:en
Short-container-title:J Headache Pain

Author:

Russo Antonio^ORCID,Silvestro Marcello,Scotto di Clemente Fabrizio,Trojsi Francesca,Bisecco Alvino,Bonavita Simona,Tessitore Alessandro,Tedeschi Gioacchino

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s10194-020-01143-0.pdf

Reference76 articles.

1. Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211.

2. Russo A, Silvestro M, Tedeschi G, Tessitore (2017) A physiopathology of migraine: what have we learned from functional imaging? Curr Neurol Neurosci Rep 17:95

3. Ford JH, Jackson J, Milligan G, Cotton S, Ahl J, Aurora SK (2017) A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache. 57:1532–1544

4. Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E et al (2012) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards Subcommittee of the American Academy of neurology and the American headache society. Neurology. 78:1337–1345

5. Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9:285–298

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study;Headache: The Journal of Head and Face Pain;2024-09-09

2. Real-world effectiveness and safety of erenumab for the treatment of migraine: A systematic review and meta-analysis;European Journal of Pharmacology;2024-08

3. Exploring Erenumab’s Efficacy and Safety for Migraine Prevention in Real-World Settings: A Systematic Review;Cureus;2024-07-28

4. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications;Frontiers in Neurology;2024-06-13

5. MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment;The Journal of Headache and Pain;2024-05-16